Abstract: A body support structure includes a base, a seat and a backrest, with the backrest connected to the base with a torsion leaf spring. The torsion leaf spring may be configured with a plurality of fingers, and/or one or more flex regions. One or more struts may be connected between the seat or backrest and the base. In another aspect, the seat and/or backrest may be supported with one or more links that provide a counter-intuitive motion. In another aspect, a link may be coupled to a support with a flexible blade.

Abstract: A method of making a photonic integrated circuit (PIC) is provided. The method comprises depositing a functional resist material layer over a substrate, disposing and pressing a stamp with a plurality of nanopatterns into the functional resist material for a period of time, and removing the stamp from the functional resist material to provide nanofeatures that are inverted versions of the nanopatterns, wherein the nanofeatures form one or more optical elements.

Abstract: Disclosed is a control system for depressurizing a work tool auxiliary circuit fluidly connected to a work tool coupled to a work machine by a quick coupler. The system may comprise a controller configured to: receive an unlock signal for the work tool; receive tool data associated with the work tool, the tool data including a target pressure for the work tool auxiliary circuit or a release duration for the relief valve; and in response to the unlock signal and the tool data, automatically actuate opening of the relief valve (a) for the release duration or (b) until the target pressure is reached in the work tool auxiliary circuit or machine-side circuit or (c) to reach and maintain the target pressure in the work tool auxiliary circuit or machine-side circuit.

Abstract: Systems and methods are described for identifying other instances of messages corresponding to a reported malicious message. A report of a malicious message from a user of a plurality users using a messaging system is received. Responsive to the report of the malicious message, plain text of content selected from the malicious message is provided. Thereafter, one or more segments of the plain text are selected as key content for construction of a search. A search is then executed in the messaging system for one or more other malicious messages corresponding to the reported malicious message using the selected one or more segments of the plain text with one or more match criteria or no criteria. The one or more other malicious messages corresponding to the reported malicious message are identified in the messaging system.

Abstract: A valve for a urostomy appliance including: a body for connection to the urostomy appliance, an inlet and an outlet, connected by a flow path, and a closure arrangement which is moveable between a closed position, in which the closure arrangement blocks the outlet, such that liquid cannot flow through the outlet, and an open position in which the outlet is open, such that liquid is permitted to flow out of the outlet, wherein the closure arrangement is detachably connectable to the body.

Abstract: Disclosed herein are formulations of nintedanib and salts thereof, indolinone derivative compounds and salts thereof for aerosolization and use of such formulations for the prevention or treatment of various fibrotic, carcinogenic, vascular and viral infectious diseases, including diseases associated with the lung, heart, kidney, liver, eye, central nervous system and surgical sites. Formulations and delivery options described herein allow for efficacious local delivery of nintedanib or a indolinone derivative compound or salt thereof. Methods include inhalation procedures, indications and manufacturing processes for production and use of the compositions described. Also included are methods for identifying compounds and indications that benefit by reformulation and inhalation administration.

Abstract: Described herein is a household care composition, which delivers active agents onto fabric or hard surfaces, in the form of a water-soluble unit dose article comprising a water-soluble fibrous structure, as well as methods for making the same.

Abstract: A compiler tool and a method of operating a compiler tool for selecting between executing a matrix multiplication operation in a weight stationary mode or in an output stationary mode on a systolic array with reconfigurable processing elements are presented. The compiler tool receives configuration parameters, energy parameters, and performance parameters as well as dimensions of the matrices to be multiplied and estimates energy consumptions and performance numbers for executing the matrix multiplication operation in the weight stationary and the output stationary modes. The compiler tool selects between operating the matrix multiplication operation in the weight stationary and the output stationary mode based on the estimated energy consumption and the estimated performance numbers.

Abstract: A reconfigurable processing element for a systolic array that is configurable for multiplying a first matrix with a second matrix to determine a result matrix in a weight stationary mode or in an output stationary mode is presented. Furthermore, a systolic array for performing matrix multiplication of a first matrix and a second matrix to determine a result matrix is presented that includes a plurality of reconfigurable processing elements that are configurable for operating in a weight stationary mode or in an output stationary mode. Moreover, a method of operating a reconfigurable processing element for a systolic array that is configured for performing matrix multiplication of a first matrix and a second matrix to determine a result matrix in a weight stationary mode or in an output stationary mode is presented.

Abstract: Provided herein are immunomodulatory proteins that exhibit neutralizing activity of BAFF and APRIL (or BAFF/APRIL heterotrimers). The immunomodulatory proteins provided herein include variant domains of Transmembrane Activator and CAML Interactor (TACI). Among provided immunodulatory proteins are TACI-Fc fusion proteins. Also provided are nucleic acid molecules encoding the immunomodulatory proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological diseases, disorders or conditions. Also provided are compositions and methods for making and using such proteins.

Abstract: A structure may include a first material, a second material joined to the first material at a junction between the first and second materials, and one or more media extending across the junction to form a continuous interconnect between the first and second materials, wherein the first and second materials are heterogeneous. The structure may further include a transition at the junction between the first and second materials. The one or more media may include a functional material which may be electrically conductive. The structure may further include a third material joined to the second material at a second junction between the second and third materials, the media may extend across the second junction to form a continuous interconnect between the first, second, and third materials, and the second and third materials may be heterogeneous.

Abstract: Provided herein are immunomodulatory proteins that exhibit neutralizing activity of BAFF and APRIL (or BAFF/APRIL heterotrimers). The immunomodulatory proteins provided herein include variant domains of Transmembrane Activator and CAML Interactor (TACI). Among provided immunodulatory proteins are TACI-Fc fusion proteins. Also provided are nucleic acid molecules encoding the immunomodulatory proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological diseases, disorders or conditions. Also provided are compositions and methods for making and using such proteins.

Abstract: Provided herein are immunomodulatory proteins that exhibit neutralizing activity of BAFF and APRIL (or BAFF/APRIL heterotrimers). The immunomodulatory proteins provided herein include variant domains of Transmembrane Activator and CAML Interactor (TACI). Among provided immunodulatory proteins are TACI-Fc fusion proteins. Also provided are nucleic acid molecules encoding the immunomodulatory proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological diseases, disorders or conditions. Also provided are compositions and methods for making and using such proteins.

Abstract: A multi-device electronic access control application, method and system. Certain aspects of the present disclosure provide for an end user mobile application that inter-operates with various types of electronic locking devices in a simple, repeatable method to enable a user to unlock any make or model of electronic access control device, if they are authorized to do so at that site, time and purpose, from a single mobile application user interface. An end user mobile application may be communicably engaged with a remote application server to integrate with enterprise backend user/site data and alarm systems, such that the end user mobile application is configured to manage user authorization/authentication, site access protocols/permissions and alarm management. An electronic access control method may comprise one or more steps for authorizing a user; suppressing an alarm; and unlocking an electronic locking device with a specified method for the given access point.

Abstract: A system includes an attraction platform and a netting system configured to capture loose articles cast from the attraction platform. The netting system includes a first structural member, a second structural member, a net extending between the first structural member and the second structural member, and a zipper interface extending between the first structural member and at least a portion of the net.

Abstract: Devices, systems, and methods include a substrate layer, a metal layer coupled to the substrate layer, an encapsulant coupled to the substrate layer and the metal layer, and a stencil-in-place structure. The encapsulant is configured to electrically isolate the metal layer from environmental conditions. The stencil-in-place structure includes a stencil substrate and conductive gel secured within a channel and a via formed by the stencil substrate, the conductive gel electrically coupled to the metal layer.

Abstract: An example operation may include one or more of receiving a natural language input submitted from a meeting device, identifying a name of an object based on the natural language input, mapping the name of the object to a name of an alternative object, and identifying a web page corresponding to the alternative object via a rule set, and displaying an option to navigate to the identified web page corresponding to the alternative object via a user interface displayed on the user device.

Abstract: Embodiments described herein enhance the visualization of certain conditions contained in a video depicting motion in a field of view, in which the enhancements include but are not limited to one or more of: adjusting the appearance of video when objects are at different distances from a video acquisition device; aligning phase of motion obtained from different video acquisition devices; accentuating frequency phenomena that may be masked or obstructed in the presence of other frequencies of motion; differentiating motion data to obtain velocity or acceleration waveforms or spectra; applying a color scheme to pixels in a scene to highlight motion with specific characteristics or to amplify motion or provide indication of absolute motion; and determining spatial or temporal regions in the video to amplify based on the predetermined parameters.

Abstract: The multi-ply tissue products that are both durable and dispersible may be manufactured using a creping process that employs a non-crosslinked vinyl acetate-ethylene polymer as a creping agent. The products generally have a Slosh time less than 2 minutes, such as less than about 60 seconds, such as less than about 45 seconds. Surprisingly, the foregoing Slosh times are achieved despite the tissue products having relatively high cross-machine direction (CD) wet tensile strength, such as greater than about 100 g/3?. Typically, increasing wet tensile strength, particularly wet CD tensile strength, negatively effects dispersability and increases Slosh time. Despite this trend, the multi-ply tissue products have a relatively high degree of wet strength and good dispersability.

Abstract: A compound of Formula (6): Formula (8): and Formula (10): are prepared and found useful in the treatment and/or prevention of diseases and conditions such as Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, fetal alcohol exposure, autism, schizophrenia, traumatic brain injury, stroke, addictions, Huntington's disease, Fragile X and Rett's syndrome.